NTI — Neurotech International Share News
0.000.00%
Last trade - 00:00- AU$25.04m
- AU$22.65m
- AU$0.04m
Australia Stock Exchange release from NEUROTECH : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from NEUROTECH : PRE_NR Ends: 08:17:55
Australia Stock Exchange release from NEUROTECH : Appendix 4E and Annual Report
Australia Stock Exchange release from NEUROTECH : Change of Director's Interest Notice
Australia Stock Exchange release from NEUROTECH : Further Success with Preclinical Testing Program - MS Models
Australia Stock Exchange release from NEUROTECH : Appendix 3G
Australia Stock Exchange release from NEUROTECH : Update - Proposed issue of securities - NTI
Australia Stock Exchange release from NEUROTECH : NTI to Present at the Gold Coast Investment Showcase
Australia Stock Exchange release from NEUROTECH : Change of Director's Interest Notice
Australia Stock Exchange release from NEUROTECH : Investor Presentation
Australia Stock Exchange release from NEUROTECH : NTI Strains Demonstrate Potential Benefits for MS Management
Australia Stock Exchange release from NEUROTECH : Proposed issue of Securities - NTI
Australia Stock Exchange release from NEUROTECH : Initial Director's Interest Notice
Australia Stock Exchange release from NEUROTECH : Appointment of Allan Cripps as Non-Executive Director
Australia Stock Exchange release from NEUROTECH : Appendix 2A
Australia Stock Exchange release from NEUROTECH : Appendix 2A
Australia Stock Exchange release from NEUROTECH : Update - Proposed issue of Securities - NTI
Australia Stock Exchange release from NEUROTECH : Update - Proposed issue of Securities - NTI
Australia Stock Exchange release from NEUROTECH : Results of Meeting